CSF-3
K号: K221260 · 2023-01-06
广告
申请人Cardiacsense
决定日期2023-01-06
产品代码DPS
咨询委员会CV
请注意，由于原文未提供具体内容，以下是一个示例翻译：
---
产品名称：[产品名称]
公司名称：[公司名称]
FDA批准号：[FDA批准号]
510(k)申请号：[510(k)申请号]
PMA申请号：[PMA申请号]
临床试验注册号：[NCT]
PubMed ID：[PMID]
产品标识符：[标识符]
产品URL：[URL]
---
请将上述示例中的[产品名称]、[公司名称]、[FDA批准号]等占位符替换为实际内容。
决定实质等同
器械摘要
CSF-3 is the device name listed in this FDA 510(k) record. The listed applicant is Cardiacsense. It received FDA 510(k) clearance on 2023-01-06 under 510(k) number K221260. The device is classified under product code DPS. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.
常见问题
What is the CSF-3?
CSF-3 is a medical device that received FDA 510(k) clearance on 2023-01-06. The listed applicant is Cardiacsense. The 510(k) number is K221260.
When did CSF-3 receive FDA 510(k) clearance?
CSF-3 received FDA 510(k) clearance on 2023-01-06, under 510(k) number K221260.
Who is the listed applicant for CSF-3?
The FDA 510(k) record lists Cardiacsense as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for CSF-3?
The FDA product code for CSF-3 is DPS.
列明Cardiacsense为申报人的其他记录
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
相关器械（代码：DPS）
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
K254255S-Patch 心脏AIWellysis Corp.K252463SE-1202系列心电图机（型号：SE-1202，SE-1202E）Edan Instruments, Inc.K251670MAC 7 静息心电图分析系统Ge Medical Systems Information Technologies, Inc.K252361AccurECG Analysis System (v2.0)Accurkardia, Inc.K252474Withings BeamO（SCT02）WithingsK250569Cardiologs Holter PlatformPhilips France Commercial
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告